First Hawaiian Bank Acquires 50 Shares of STERIS plc (NYSE:STE)

First Hawaiian Bank lifted its holdings in STERIS plc (NYSE:STE) by 0.4% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 13,857 shares of the medical equipment provider’s stock after acquiring an additional 50 shares during the quarter. First Hawaiian Bank’s holdings in STERIS were worth $3,115,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. GAMMA Investing LLC lifted its holdings in shares of STERIS by 39.6% in the 1st quarter. GAMMA Investing LLC now owns 701 shares of the medical equipment provider’s stock worth $158,000 after acquiring an additional 199 shares during the last quarter. CWM LLC lifted its holdings in shares of STERIS by 8.6% in the 1st quarter. CWM LLC now owns 2,206 shares of the medical equipment provider’s stock worth $496,000 after acquiring an additional 174 shares during the last quarter. Cullen Investment Group LTD. lifted its holdings in shares of STERIS by 6.1% in the 1st quarter. Cullen Investment Group LTD. now owns 6,519 shares of the medical equipment provider’s stock worth $1,410,000 after acquiring an additional 373 shares during the last quarter. Symmetry Partners LLC bought a new stake in shares of STERIS in the 1st quarter worth approximately $270,000. Finally, Nomura Holdings Inc. bought a new stake in STERIS during the 4th quarter valued at $441,000. 94.69% of the stock is currently owned by institutional investors.

Insider Transactions at STERIS

In other news, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total value of $267,312.56. Following the sale, the vice president now directly owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Jacqueline B. Kosecoff sold 4,584 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $231.53, for a total value of $1,061,333.52. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the sale, the vice president now directly owns 6,677 shares in the company, valued at $1,546,660.28. The disclosure for this sale can be found here. Insiders have sold 7,762 shares of company stock valued at $1,798,477 in the last three months. 1.14% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on STE. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, May 10th. Piper Sandler reiterated a “neutral” rating and set a $225.00 price target (up from $220.00) on shares of STERIS in a report on Friday, May 10th. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Thursday, May 9th. Finally, StockNews.com upgraded shares of STERIS from a “hold” rating to a “buy” rating in a report on Saturday, June 15th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average price target of $241.60.

STERIS Stock Up 0.2 %

Shares of NYSE STE opened at $216.50 on Thursday. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49. STERIS plc has a 12 month low of $195.47 and a 12 month high of $254.00. The firm has a market capitalization of $21.40 billion, a PE ratio of 56.68 and a beta of 0.85. The firm has a fifty day simple moving average of $217.87 and a two-hundred day simple moving average of $220.25.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, topping the consensus estimate of $2.41 by $0.17. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. During the same period in the prior year, the business earned $2.30 EPS. Equities analysts expect that STERIS plc will post 9.24 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio is presently 54.45%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.